Serum Protein S-100 Predicts Clinical Outcome in Patients with Melanoma Treated with Adjuvant Interferon – Comparison with Tyrosinase RT-PCR

Publisher： Karger

E-ISSN： 1423-0232|68|4-6|341-349

ISSN： 0030-2414

Source： Oncology, Vol.68, Iss.4-6, 2005-08, pp. : 341-349

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low Thymidylate Synthase Expression in the Primary Tumor Predicts Favorable Clinical Outcome in Resected Gastric Cancer Patients Treated with Adjuvant Tegafur

By  

Oncology, Vol. 66, Iss. 3, 2004-06 ,pp. : 226-233

Karger

Access to resources Recommend Favorite

Serum S100B Levels Correlate with Clinical Benefit in a Metastatic Melanoma Patient Treated by CTLA-4 Blockade: A Case Report

By  

Oncology Research and Treatment, Vol. 36, Iss. 10, 2013-09 ,pp. : 578-581

Karger

Access to resources Recommend Favorite

Effects of Adjuvant Interferon‐alpha Low‐dose Therapy in Melanoma Patients on Serum Inhibin B

By  

THE JOURNAL OF DERMATOLOGY, Vol. 27, Iss. 10, 2000-10 ,pp. : 639-642

John Wiley & Sons Inc

Access to resources Recommend Favorite

Heterogenous S-100B Protein Expression Patterns in Malignant Melanoma and Association with Serum Protein Levels

By  

Oncology, Vol. 64, Iss. 4, 2003-05 ,pp. : 374-379

Karger

Access to resources Recommend Favorite

High neutrophil‐to‐lymphocyte ratio predicts poor clinical outcome in patients with castration‐resistant prostate cancer treated with docetaxel chemotherapy

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 9, 2015-09 ,pp. : 827-833

John Wiley & Sons Inc

Access to resources Recommend Favorite